BIOREGENX, INC. (BRGX) Gross margin 2021–2025
BIOREGENX, INC. (BRGX) gross margin by fiscal year — reported gross profit divided by reported revenue.
81.1%FY2025 · since FY2021: 99.7% → 81.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 81.1% | +10.2 pp |
| FY2024 | 70.9% | +3.1 pp |
| FY2023 | 67.8% | -32.2 pp |
| FY2022 | 100.0% | +0.3 pp |
| FY2021 | 99.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BRGX financial trends
BRGX RevenueBRGX Net incomeBRGX Net marginBRGX Gross profitBRGX Operating incomeBRGX Operating marginBRGX Operating cash flowBRGX Free cash flowBRGX Capital expendituresBRGX Return on equityBRGX Stock buybacksBRGX Dividends paidBRGX Total assetsBRGX Total liabilitiesBRGX Shareholders’ equityBRGX overview →